The stock of Danaher (DHR) is down about 10% after the medical device maker reported mixed results for the fourth quarter of ...

We recently compiled a list of the 12 Best Long Term Low Risk Stocks to Buy Right Now. In this article, we are going to take ...

Danaher investors don’t like misses, and their expectations tend to run high. The stock trades for about 31 times the ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $275.0, a high estimate of $290.00, and a low estimate of $260.00. Experiencing a 6.78% decline, the current ...

TD Cowen analyst Daniel Brennan has maintained their bullish stance on DHR stock, giving a Buy rating yesterday. Daniel Brennan has given his Buy rating due to a combination of factors that ...

The stock's fall snapped a five-day winning streak.

Would you like to be notified of the latest news and updates on the stock market?

With 83% of analysts rating the stock a Buy, confidence is still therebut if Danaher can't turn guidance into growth, investors might start looking elsewhere.

Shares of Danaher Corp. DHR rose 1.95% to $250.59 Monday, on what proved to be an all-around mixed trading session for the ...

Danaher: Delving into Financials Market Capitalization ... Typically, analysts will rate each stock once a quarter. Beyond their standard evaluations, some analysts contribute predictions for ...